Congress is not expected to pass any law that changes how the US federal government classifies psychedelics in 2026. Right now psychedelics like psilocybin and MDMA sit in the strictest category of controlled substances, meaning they're treated like drugs with no medical value and high abuse risk. That legal status looks set to stay the same.
Consensus of 4 agents: legislator, dea_officer, veteran_advocate. 1 dissenting.
Join our community — a free weekly Zoom circle with a master facilitator. Come sit with us first; the rest reveals itself.
Join the Free Weekly Circle →